Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

NCT00149227 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3031

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Ischemic Heart Disease
Congestive Heart Failure
Stroke

Interventions

DRUG: Valsartan
DRUG: Non-ARB

Sponsor

Kyoto Prefectural University of Medicine